Efficacy and Safety of Ultrasound Modulation of Stellate Ganglion for the Prevention of Ventricular Arrhythmia in Patients With ST-segment Elevation Myocardial Infarction
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.
Also called NCT07587294
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT07587294
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07587294. Randomized; quadruple masking; primary purpose treatment. Start 2026-05-15 (actual); primary completion 2027-04-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Ultrasound Modulation of Stellate Ganglion for the Prevention of Ventricular Arrhythmia in Patients With ST-segment Elevation Myocardial Infarction
- Acronym
- US-PRAY
- Condition
- Acute ST-segment Elevation Myocardial Infarction (Patients Undergoing Emergency PCI)
- Intervention (Device)
- Ultrasound modulation of the left stellate ganglion
- Intervention (Device)
- Sham ultrasound modulation of the left stellate ganglion
- Lead sponsor
- Renmin Hospital of Wuhan University
- Collaborator
- Wuhan Third Hospital
- Collaborator
- Xiangyang Central Hospital
- Collaborator
- Wuhan Central Hospital
- Collaborator
- Taihe Hospital
- Collaborator
- Jingzhou Central Hospital
- Collaborator
- Huangshi Central Hospital
Record details
- Record id
cardio:ct-nct07587294- Content hash
967dcefd07654f37dff5b500877d89b54175c04cc874a0aa4170df03826ee19d